Aromatase (AR, CYP19) is a CYP450 enzyme, and its inhibitors examestane, anastrozole, and letrozole are used in the treatment of ER+ (estrogen dependent) breast cancer [176]. Here, CYP19A1 is linked to breast carcinoma.